Targeted therapies: the maths behind combination therapy.
about
Bioinformatic approaches to augment study of epithelial-to-mesenchymal transition in lung cancerOvercoming resistance to BRAF inhibition in BRAF-mutated metastatic melanomaCaspase mediated synergistic effect of Boswellia serrata extract in combination with doxorubicin against human hepatocellular carcinoma.
P2860
Targeted therapies: the maths behind combination therapy.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Targeted therapies: the maths behind combination therapy.
@en
Targeted therapies: the maths behind combination therapy.
@nl
type
label
Targeted therapies: the maths behind combination therapy.
@en
Targeted therapies: the maths behind combination therapy.
@nl
prefLabel
Targeted therapies: the maths behind combination therapy.
@en
Targeted therapies: the maths behind combination therapy.
@nl
P1476
Targeted therapies: the maths behind combination therapy
@en
P2093
Rebecca Kirk
P356
10.1038/NRCLINONC.2013.131
P407
P50
P577
2013-07-16T00:00:00Z